A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR [desvenlafaxine] in Adult Female Outpatients With Fibromyalgia Syndrome.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR [desvenlafaxine] in Adult Female Outpatients With Fibromyalgia Syndrome.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Pregabalin (Primary) ; Desvenlafaxine
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 24 Feb 2010 Actual number of patients added to 125 as reported by ClinicalTrials.gov.
    • 26 Nov 2008 Status changed from recruiting to discontinued, as reported in ClinicalTrials.gov record.
    • 10 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top